Rage antagonists as agents to reverse amyloidosis and diseases associated therewith

Details for Australian Patent Application No. 2004251599 (hide)

Owner Transtech Pharma, Inc.

Inventors Rothlein, Robert; Mjalli, Adnan M. M.; Andrews, Robert C.; Shen, Jane M.

Agent Pizzeys

Pub. Number AU-A-2004251599

PCT Pub. Number WO2005/000295

Priority 60/471,969 20.05.03 US

Filing date 20 May 2004

Wipo publication date 6 January 2005

International Classifications

A61K 031/4184

A61P 025/28 Drugs for disorders of the nervous system

A61K 031/4164 - 1,3-Diazoles

Event Publications

27 October 2005 PCT application entered the National Phase

  PCT publication WO2005/000295 Priority application(s): WO2005/000295

23 November 2006 Change of Name(s) of Applicant(s), Section 104

  Transtech Pharma Inc. The name of the applicant has been changed to TransTech Pharma, Inc.

17 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004251600-Methods and compositions for modulating serum cortisol levels

2004251598-Pancreatic cancer treatment